Table 2.
Number of deaths and ASMR for interstitial lung disease and pulmonary sarcoidosis in 1990 and 2021, and changes in number of deaths and ASMR from 1990 to 2021
| Item | 1990 | 2021 | 1990–2021 | ||||
|---|---|---|---|---|---|---|---|
| Number | ASMR per 100,000 | Number | ASMR per 100,000 | Percentage changes, % | AAPC, % | EAPC, % | |
| Global | 54967.23 (44761.39-68391.19) | 1.52(1.25–1.87) | 188222.37 (161405.66-212251.52) | 2.28(1.96–2.56) | 0.50(0.32–0.74) | 1.32(1.16–1.48) | 1.55(1.42–1.69) |
| Sex | |||||||
| Male | 31182.61(24196.09-39011.60) | 2.01(1.61-2.48) | 103056.70(84156.40-115833.40) | 2.90(2.40–3.24) | 0.44(0.25-0.66) | 1.18(1.02–1.35) | 1.41(1.28–1.53) |
| Female | 23784.63(18180.45-32746.57) | 1.17(0.90-1.60) | 85165.67(68720.00-105539.29) | 1.83(1.48–2.27) | 0.56(0.35-0.98) | 1.45(1.27–1.63) | 1.7(1.54–1.86) |
| SDI* | |||||||
| Low | 4477.69(2158.18-6437.86) | 2.34(1.19-3.27) | 11083.58(6589.04-15793.99) | 2.61(1.56–3.75) | 0.11(−0.17-0.56) | 0.38(−0.00–0.76) | 0.63(0.45–0.81) |
| Low-middle | 13152.92(7523.03-20491.26) | 2.48(1.46-3.81) | 39117.86(26539.67-53611.72) | 3.09(2.12–4.23) | 0.24(−0.01-0.79) | 0.76(0.19–1.34) | 0.94(0.83–1.06) |
| Middle | 8992.62(7004.00-12322.48) | 1.07(0.85-1.45) | 33341.76(27822.48-40427.28) | 1.39(1.16–1.68) | 0.29(0.06-0.66) | 0.88(0.63–1.12) | 1.15(1.03–1.27) |
| High-middle | 8237.68(7611.50-9226.60) | 0.91(0.84-1.02) | 22850.83(20008.19-25163.44) | 1.19(1.04–1.31) | 0.31(0.16-0.46) | 0.92(0.57–1.27) | 1.24(1.09–1.39) |
| High | 20063.97(18621.72-20871.04) | 1.79(1.66-1.86) | 81732.30(71243.83-88091.88) | 3.44(3.05–3.69) | 0.92(0.81-1.03) | 2.16(1.91–2.41) | 2.3(2.06–2.55) |
ASMR Age-standardized Mortality Rate, AAPCs Average Annual Percentage Change, SDI Sociodemographic Index, EAPC Estimated Annual Percentage Change. *P < 0.05